Home

Jennifer K. Moses

CIK 1706667 · CFO · last filed 2026-07-02

Jennifer K. Moses is a CFO who has filed 31 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for VRDN, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$378.4K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

31

Lifetime Open-Market Net

-$378.4K

Filer Profile

Reported Address
79 TW ALEXANDER DRIVE
4501 RESEARCH COMMONS, SUITE 100
RESEARCH TRIANGLE PARK, NC 27709
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VRDN Director — $21.43 — $0 6 2026-07-02
G1 Therapeutics, Inc. (GTHX) Delisted CFO 60,188 $7.15 $430.3K -$378.4K 25 2023-01-05

Recent Filings

31 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 VRDN Grant (A) — $0 EDGAR
2025-07-02 VRDN Grant (A) — $0 EDGAR
2024-06-28 VRDN Grant (A) — $0 EDGAR
2023-06-16 VRDN Grant (A) — $0 EDGAR
2023-01-05 G1 Therapeutics, Inc. (GTHX) Delisted Mixed +19,932 -$13.1K EDGAR
2022-06-10 VRDN Grant (A) — $0 EDGAR
2022-02-02 G1 Therapeutics, Inc. (GTHX) Delisted Exer (M) +2,333 $9.6K EDGAR
2022-01-05 G1 Therapeutics, Inc. (GTHX) Delisted Mixed +10,555 -$15.3K EDGAR
2021-07-15 VRDN Grant (A) — $0 EDGAR
2021-03-04 G1 Therapeutics, Inc. (GTHX) Delisted Exer (M) +3,000 $11.2K EDGAR
Showing 1–10 of 31
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.